Jinghua Pharmaceutical Group Co., Ltd. (SHE:002349)
China flag China · Delayed Price · Currency is CNY
6.85
-0.15 (-2.14%)
Nov 13, 2026, 3:04 PM CST

SHE:002349 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
1,4641,4461,3881,4961,5501,336
Other Revenue
13.8513.8513.6315.4122.5821.41
1,4771,4601,4021,5121,5731,358
Revenue Growth
1.95%4.13%-7.25%-3.90%15.85%5.97%
Cost of Revenue
715.55713.15719.73781.18847.06739.21
Gross Profit
761.89746.8682.36730.58726618.66
Selling, General & Admin
374.51394.33366.72346.78401.01352.64
Research & Development
7064.9961.7964.6286.9874.76
Other Operating Expenses
18.7120.0417.4817.7722.3920.17
Operating Expenses
464.33479.82449.36431.89514.64462.16
Operating Income
297.56266.98233298.69211.36156.51
Interest Expense
-0.81-0.57-1.34-2.57-6.79-12.94
Interest & Investment Income
27.0230.348.3823.8739.7114.16
Currency Exchange Gain (Loss)
-2.55-2.552.342.356.86-1.48
Other Non Operating Income (Expenses)
-5.66-0.21-0.30.43-1.241.45
EBT Excluding Unusual Items
315.56293.96282.09322.76249.9157.7
Gain (Loss) on Sale of Investments
4.344.173.826.834.9931.44
Gain (Loss) on Sale of Assets
-0.1-0.01-0.2-0.09-0.06-0.58
Asset Writedown
-0.94-1.14-2.13-4.52-16.96-16.7
Other Unusual Items
7.666.629.754.7112.347.03
Pretax Income
326.52303.61293.32329.7250.21178.89
Income Tax Expense
43.9241.7745.8553.2337.9238.93
Earnings From Continuing Operations
282.6261.84247.47276.47212.29139.96
Minority Interest in Earnings
-49.98-42.55-34.81-28.77-0.0620.74
Net Income
232.62219.28212.65247.7212.23160.7
Net Income to Common
232.62219.28212.65247.7212.23160.7
Net Income Growth
3.48%3.12%-14.15%16.71%32.06%44.79%
Shares Outstanding (Basic)
814819814814814814
Shares Outstanding (Diluted)
817819814814814814
Shares Change
-0.27%0.58%-0.01%0.02%-0.00%-0.03%
EPS (Basic)
0.290.270.260.300.260.20
EPS (Diluted)
0.280.270.260.300.260.20
EPS Growth
3.76%2.53%-14.13%16.69%32.07%44.83%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
259.96320.54280.1262.93296.8225.02
Free Cash Flow Per Share
0.320.390.340.320.360.28
Dividend Per Share
0.0900.0900.0800.0920.0800.060
Dividend Growth
12.50%12.50%-13.04%15.00%33.33%46.34%
Gross Margin
51.57%51.15%48.67%48.33%46.15%45.56%
Operating Margin
20.14%18.29%16.62%19.76%13.44%11.53%
Profit Margin
15.75%15.02%15.17%16.38%13.49%11.83%
Free Cash Flow Margin
17.59%21.96%19.98%17.39%18.87%16.57%
EBITDA
380.22346.42308.14382.89319.43257.8
EBITDA Margin
25.74%23.73%21.98%25.33%20.31%18.99%
D&A For EBITDA
82.6679.4375.1484.21108.07101.29
EBIT
297.56266.98233298.69211.36156.51
EBIT Margin
20.14%18.29%16.62%19.76%13.44%11.53%
Effective Tax Rate
13.45%13.76%15.63%16.14%15.16%21.76%
Revenue as Reported
1,4771,4601,4021,5121,5731,358
Advertising Expenses
-9.3113.6913.657.2711.6